Cholesterol Pathway Gene Variants and Reduced Keratinocyte Cholesterol Support a Final Common Druggable Pathway in Hyperproliferative Inflammatory Skin Diseases

Hyperproliferative inflammatory skin disease (HISD) is frequently seen in rare monogenic diseases of cholesterol metabolism and responds to topical cholesterol/statin. We hypothesized that aberrant cholesterol metabolism within keratinocytes could be important in HISD more generally, driven by either immunological or lipid pathway genetic variation. Whereas other epidermal lipids have been well-characterized in HISDs, cholesterol and its metabolites have not. In this study, using comprehensive 2-dimensional gas chromatography 3-dimensional mass spectrometry, we found that primary keratinocytes from diverse monogenic HISDs (inflammatory linear verrucous epidermal nevi, n = 14; CHILD [congenital hemidysplasia with ichthyosiform erythroderma and limb defects] syndrome, n = 2) and from plaque psoriasis (n = 2) demonstrate significantly reduced mean cholesterol across all patient groups compared with those across the controls. This striking abnormality appears causally implicated because treatment in vitro with cholesterol and statin rescued the cellular hyperproliferation. Using SNPsea and burden analysis of large international psoriasis cohorts, we went on to show that GWAS hits were significantly enriched in proximity to genes encoding lipid metabolic pathways and that rare variants in lipid metabolic pathway genes were significantly enriched in patients with psoriasis. These data identify a final common pathway of aberrant keratinocyte cholesterol metabolism in HISD, which should be drugged topically to avoid first-pass metabolism. In parallel, we implicate genetic variation in lipid pathway genes in psoriasis susceptibility, potentially explaining the comorbidity of abnormal serum lipid profile and psoriasis.

Authors

Institutions

Publication Details

Journal
Journal of Investigative Dermatology
Published
2025-04-22
DOI
https://doi.org/10.1016/j.jid.2025.02.157
Citations
2
Primary Topic
Cell Adhesion Molecules Research
Type
article
Field-Weighted Citation Impact
3.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cholesterol Pathway Gene Variants and Reduced Keratinocyte Cholesterol Support a Final Common Druggable Pathway in Hyperproliferative Inflammatory Skin Diseases

Patricia Barral, Veronica A. Kinsler, Connor Hughes, Noreen Muwanga-Nanyonjo et al.
2 citations
Journal of Investigative Dermatology
Cell Adhesion Molecules Research
3.24
article

Cholesterol Pathway Gene Variants and Reduced Keratinocyte Cholesterol Support a Final Common Druggable Pathway in Hyperproliferative Inflammatory Skin Diseases

Patricia Barral, Veronica A. Kinsler, Connor Hughes, Noreen Muwanga-Nanyonjo, Nicole Knöpfel, James K. Ellis, Ignacio del Valle, Melissa Riachi, Youssef Khalil, Michael A. Simpson, Satyamaanasa Polubothu, Dale Bryant, Mariana Silva dos Santos, Alicia L. Bruzos, Peter T. Clayton, Sara Barberan-Martin, Gavin Kelly, Susana A. Palma-Duran, Aimie Sauvadet, Enrica Calvani, Wei-Li Di, Philippa B. Mills, Juliet N. Barker, Charlotte Chaloner, James I. MacRae, Neil Bulstrode, James Christopher Lee, Nick Dand
article en
2 citations

Abstract

Hyperproliferative inflammatory skin disease (HISD) is frequently seen in rare monogenic diseases of cholesterol metabolism and responds to topical cholesterol/statin. We hypothesized that aberrant cholesterol metabolism within keratinocytes could be important in HISD more generally, driven by either immunological or lipid pathway genetic variation. Whereas other epidermal lipids have been well-characterized in HISDs, cholesterol and its metabolites have not. In this study, using comprehensive 2-dimensional gas chromatography 3-dimensional mass spectrometry, we found that primary keratinocytes from diverse monogenic HISDs (inflammatory linear verrucous epidermal nevi, n = 14; CHILD [congenital hemidysplasia with ichthyosiform erythroderma and limb defects] syndrome, n = 2) and from plaque psoriasis (n = 2) demonstrate significantly reduced mean cholesterol across all patient groups compared with those across the controls. This striking abnormality appears causally implicated because treatment in vitro with cholesterol and statin rescued the cellular hyperproliferation. Using SNPsea and burden analysis of large international psoriasis cohorts, we went on to show that GWAS hits were significantly enriched in proximity to genes encoding lipid metabolic pathways and that rare variants in lipid metabolic pathway genes were significantly enriched in patients with psoriasis. These data identify a final common pathway of aberrant keratinocyte cholesterol metabolism in HISD, which should be drugged topically to avoid first-pass metabolism. In parallel, we implicate genetic variation in lipid pathway genes in psoriasis susceptibility, potentially explaining the comorbidity of abnormal serum lipid profile and psoriasis.

Journal of Investigative DermatologyVol. 145(11)
St Thomas' Hospital (GB), King's College London (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Great Ormond Street Hospital (GB), The Francis Crick Institute (GB), Thomas Foundation (AU), King's College School (GB), Institute of Infection and Immunity (CA), Food Research and Development Institute (BG), University College London (GB)
Zero hunger
Openalex Percentile: Top 10%
Cell Adhesion Molecules Research
3.24
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.